237 related articles for article (PubMed ID: 23056468)
1. Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
Byron SA; Min E; Thal TS; Hostetter G; Watanabe AT; Azorsa DO; Little TH; Tapia C; Kim S
PLoS One; 2012; 7(10):e46823. PubMed ID: 23056468
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity.
Coles AH; Gannon H; Cerny A; Kurt-Jones E; Jones SN
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11423-8. PubMed ID: 20534538
[TBL] [Abstract][Full Text] [Related]
3. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes.
Nozell S; Laver T; Moseley D; Nowoslawski L; De Vos M; Atkinson GP; Harrison K; Nabors LB; Benveniste EN
Mol Cell Biol; 2008 Nov; 28(21):6632-45. PubMed ID: 18779315
[TBL] [Abstract][Full Text] [Related]
4. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Hou Y; Zhang Z; Xu Q; Wang H; Xu Y; Chen K
Oncogene; 2014 Apr; 33(15):1997-2003. PubMed ID: 23624912
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.
Li S; Fan T; Liu H; Chen J; Qin C; Ren X
Mol Biol Rep; 2013 Oct; 40(10):5723-32. PubMed ID: 24057236
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-N-nitro-N-nitrosoguanidine-mediated ING4 downregulation contributed to the angiogenesis of transformed human gastric epithelial cells.
Chen Y; Fu R; Xu M; Huang Y; Sun G; Xu L
Life Sci; 2018 Apr; 199():179-187. PubMed ID: 29496496
[TBL] [Abstract][Full Text] [Related]
8. SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer.
Yan R; He L; Li Z; Han X; Liang J; Si W; Chen Z; Li L; Xie G; Li W; Wang P; Lei L; Zhang H; Pei F; Cao D; Sun L; Shang Y
Genes Dev; 2015 Mar; 29(6):672-85. PubMed ID: 25792601
[TBL] [Abstract][Full Text] [Related]
9. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.
Garkavtsev I; Kozin SV; Chernova O; Xu L; Winkler F; Brown E; Barnett GH; Jain RK
Nature; 2004 Mar; 428(6980):328-32. PubMed ID: 15029197
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation.
Kawiak A; Domachowska A
PLoS One; 2016; 11(10):e0164064. PubMed ID: 27727280
[TBL] [Abstract][Full Text] [Related]
11. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Shatnawi A; Ayoub NM; Alkhalifa AE
Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
13. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.
Tapia C; Zlobec I; Schneider S; Kilic E; Güth U; Bubendorf L; Kim S
Hum Pathol; 2011 Jul; 42(7):983-90. PubMed ID: 21315418
[TBL] [Abstract][Full Text] [Related]
16. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity.
Hsu RM; Zhong CY; Wang CL; Liao WC; Yang C; Lin SY; Lin JW; Cheng HY; Li PY; Yu CJ
Cell Commun Signal; 2018 Apr; 16(1):19. PubMed ID: 29703230
[TBL] [Abstract][Full Text] [Related]
17. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
[TBL] [Abstract][Full Text] [Related]
18. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
